Why is Marksans Pharma falling/rising?

As of 05-Sep, Marksans Pharma Ltd is experiencing a decline in its stock price, currently at Rs 169.95, down by 1.25 (-0.73%). The stock has underperformed its sector by 0.66% today and has been on a consecutive downward trend for the last two days, resulting in a total drop of 1.73%. Over the past month, the stock has seen a significant decline of 24.83%, and year-to-date, it has fallen by 42.63%. Despite a high management efficiency indicated by a return on equity (ROE) of 17.66% and a low debt-to-equity ratio, the company has reported poor long-term growth, with operating profit declining at an annual rate of -0.29% over the last five years. Additionally, the stock's recent performance is overshadowed by a negative earnings report, with a substantial drop in profit before tax and profit after tax compared to previous quarters.
In the broader market context, the Sensex has shown a positive return of 1.13% over the past week, contrasting sharply with Marksans Pharma's negative performance. The stock's year-over-year return of -34.39% significantly underperforms the market's decline of only -1.81%. While there has been an increase in investor participation with a rise in delivery volume, the stock remains below its moving averages, indicating a bearish trend. The overall market conditions have not favored Marksans Pharma, as it continues to struggle against both its historical performance and the broader market benchmarks.